期刊文献+

胃癌术后并发血栓形成的危险因素分析 被引量:4

下载PDF
导出
摘要 目的探讨胃癌术后并发血栓形成的危险因素。方法对298例胃癌术后患者病例资料进行分析,其中41例术后并发血栓形成。选择14个可能对胃癌术后并发血栓形成产生影响的特征性因素,通过计算机Logistic回归模型进行多因素分析。结果手术方式、糖皮质激素应用、病理类型、化疗、冠心病病史或大动脉粥样硬化史、糖尿病病史、血小板计数、D二聚体值、血浆同型半胱氨酸水平是胃癌术后并发血栓形成的独立危险因素。结论降低胃癌术后并发血栓形成的发生率,应注重手术方式的选择,对于有基础血管病变、血小板计数、D二聚体、血浆同型半胱氨酸水平升高的患者,应积极预防血栓形成的发生。
出处 《中国乡村医药》 2015年第7期23-25,共3页
  • 相关文献

参考文献10

二级参考文献69

  • 1赵海霞.组织型纤溶酶原激活物研究进展[J].国外医学(输血及血液学分册),1995,18(1):19-23. 被引量:21
  • 2GATT A, MAKRIS M, GATT A, et al. Hyperhomocysteinemia and venous thrombosis[J].Semin Hematol,2007,44(2) : 70-76.
  • 3GEMMATI D, SERINO ML,TRIVELLATO C, et al. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients [J]. Haematologica. 1999,84 (9) : 824-828.
  • 4WARREN S,EBERHARDT TP. Mesenteric venous thrombosis [J]. Surg Gynecol Obstet, 1935,61(2) : 102.
  • 5STRANDHAGEN E,ZETFERBERG H,AIRES N,et al.The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study[ J ]. Int J Mol Med, 2004,13 (6) : 811-815.
  • 6HO CH,KUO BI,KONG CW,et al. Influence of methylenetetrahy- drofolate reduetase (MTHFR) C677T polymorphism, B vitamins and other factors on plasma homocysteine and risk of thromboembolie disease in Chinese[J]. J Chin Med Assoc, 2005,68 (12): 560-565.
  • 7Kitano S,Shiraishi N,Uyama I,et al.A multieenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan[J].Ann Surg,2007,245(1):68-72.
  • 8Lee SI,Choi YS,Park D J,et al.Comparative study of laparoseopy-assisted distal gastrectomy and open distal gastreetomy[J].J Am Coil Surg,2006,202(6):874-880.
  • 9Maillo CL,Martin E,L閜ez J,et al.Effect of pneumoperitoneum on venous hemodynamics during iaparoscopic cholecystectomy.Influence of patients' age and time of surgery[J].Med Clin(Bare),2003,120(9):330-334,
  • 10The Japanese Gastric Cancer Association.Guidelines for the treatment of gastric cancer[G].2nd ed.Tokyo:Kanehara,2004.

共引文献76

同被引文献32

  • 1Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 vl.1, Cancer Incidence and Mortality Worldwide : IARC CancerBase No. 11 [ EB/OL ] . http ://globocan.iarc.fr.
  • 2Khorana AA, Francis CW, Culakova E, et ah ThromI~oembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy [ J ] . J Thrnmb Haemost, 2007, 5 ( 3 ) : 632-634.
  • 3Elyamany G, Alzahrani AM, Bukhary E. Cancer-associated thrombosis : an overview [ J ] . Clin Med Insights Oncol, 2014, 8 : 129-137.
  • 4Brose KM, Lee AY. Cancer-associated Ihrombosis : prevention and treatment [ J ] . Curr Oncnl, 2008, 15 ( Suppl 1 ) : S58-S67.
  • 5Khorana AA, Dalai M, Lin J, et al. Incidence and predictors of venous thromboembolism ( VTE ) among ambulatory high-risk cancer patients undergoing chemotherapy in the Uniled States [ J ] . Cancer, 2013, 119 ( 3 ) : 648-655.
  • 6Lee AY. Thrmnbosis in cancer : an updale on prevenlion, Irealmenl, and survival benefits of anticoagulants [ J ] . Hematology Am Soc Hematol Educ Program, 2010 : 144-149.
  • 7Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients : the Sirius stmty [ J ] . Arch Intern Med, 2000, 160 ( 22 ) : 3415-3420.
  • 8Amer MH. Cancer-associated thrombosis : clinical presenladon and survival [J]. Cancer Manag Res, 2013, 5 : 165-178.
  • 9Tukaye DN, Brink H, Baliga R. Venous thrombooembolism in cancer patients : risk assessment, prevention and management [ J ] . l:tlture Cardiol, 2016, 12 ( 2 ) : 221-235.
  • 10Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothromboti, mutations, and the risk of venous thrombosis [ J j . JAMA, 2005, 293 ( 6 ) : 715-722.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部